Close

Anti-EPCAM DNA-encoded mAb (DMAb), pVAX1 (DMAb-0200-CN)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-EPCAM DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • EPCAM
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-1080-YY 4A7 Mouse IgG1
DMAb-0250-FY 323/A3 Mouse Human IgG1, κ MCF-7 human breast cancer cells
DMAb-0251-FY 60N5D8 Mouse Human IgG2b, κ Within the range of amino acids 289-335 were used as the immunogen for the EpCAM antibody
DMAb-0252-FY 7B5C10 Mouse Human IgG1 Purified recombinant fragment of human EPCAM expressed in E.coli
DMAb-0253-FY ABM4D85 Mouse Human IgG2a, κ
DMAb-0254-FY AUA1 Mouse Human IgG1 LoVo cell line preparation
DMAb-0255-FY B1368M Mouse IgG2b Recombinant fusion of EpCAM peptide and human thioredoxin
DMAb-0256-FY Ber-EP4 Mouse Human IgG1 BALB/C mice were immunized with human breast carcinoma cell line, MCF-7
DMAb-0257-FY EGP40/1110 Mouse IgG2b, κ A recombinant human EpCAM fragment from the cytoplasmic domain
DMAb-0258-FY EGP40/1372 Mouse Human IgG A recombinant human EpCAM fragment from the extracellular domain
DMAb-0259-FY EGP40/1373 Mouse Human IgG2b Recombinant human EpCAM protein fragment from the extracellular domain
DMAb-0260-FY EGP40/1555R Rabbit Human IgG, κ A synthetic peptide from the N-terminus of human TACSTD1 protein
DMAb-0261-FY EGP40/1798 Mouse Human IgG2b, κ Recombinant human EpCAM protein fragment from the extracellular domain
DMAb-0262-FY EGP40/837 Mouse Human IgG1, κ Recombinant human TACSTD1 protein
DMAb-0263-FY Epcam/1158 Mouse IgG1 It is expressed on baso-lateral cell surface in most simple epithelia and a vast majority of carcinomas
DMAb-0264-FY ESA214 Mouse Human IgG1 Small cell lung carcinoma. Remarks: Molecular weight of antigen: 40 kDa
DMAb-0265-FY G8.8 Rat Mouse IgG2a Glycoconjugates from Balb/C mouse derived medullary thymic epithelial cells
DMAb-0266-FY HEA125 Mouse Human IgG1 Living human colon carcinoma cell line HT-29
DMAb-0267-FY MOC-31 Mouse Human IgG1
DMAb-0268-FY PAN-EpCAM Cocktail Mouse Human IgG1, κ Recombinant human Ep-CAM protein
DMAb-0269-FY VU-1D9 Mouse Human IgG1
DMAb-0775-CQ GZ-20 Mouse Rat IgG1
DMAb-0776-CQ MOC-181 Mouse Human IgG2a
DMAb-0777-CQ HEA-125 Mouse Human IgG1
DMAb-0778-CQ B8-4 Mouse Human IgG1, κ Recombinant human CD326 (EpCAM), Fc fusion protein
DMAb-0265-FY G8.8 Rat Mouse IgG2a, κ
DMAb-0266-FY HEA125 Mouse IgG1

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-EPCAM DNA-encoded mAb (DMAb), pVAX1 (DMAb-0200-CN). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.